Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Research & insights

Why a peptide experiment needs a matching solvent control

By NHD Technical TeamPublished
Editorial comic illustration for quality research learning
AI-generated educational illustration; not an NHD facility photograph or a measured batch result.

If a peptide solution changes an experimental readout, the peptide is not the only possible cause. The solvent or buffer added with it may also matter. A matching vehicle control makes the comparison easier to interpret.

What a vehicle control is

It contains the relevant solvent or buffer contribution without the test peptide. The goal is to make the surrounding conditions comparable. A plain-water control is not a match for a peptide sample introduced in a different solvent mixture.

A clear numerical example

Suppose one laboratory treatment contains 1 microlitre of DMSO stock in a final volume of 100 microlitres. The final DMSO contribution is 1% by volume. A vehicle control for that condition should reflect the same solvent contribution under the approved assay design. This is a volume calculation, not a safe solvent limit.

Compare the whole concentration series

If stock addition volumes change across a series, the solvent concentration may change too. A response curve can then combine a peptide effect and a vehicle effect. Consider a design that controls the vehicle contribution, and assess compatibility with the specific assay.

What to record and request

Record the stock solvent, additions, final volumes and control composition. For material enquiries, provide the intended assay and any solvent restrictions so suitability can be assessed. Do not interpret “dissolved” as proof of peptide stability or biological compatibility; those remain separate questions.

Related materials and next steps

Explore the NHD catalogue records for KPV, LL-37. Confirm the required molecular form, quantity and lot-document availability before relying on a listing for procurement. A catalogue record does not establish equivalence to a published study material.

Send the product or sequence, quantity and document requirements. For more background, browse the analytical methods guides and research glossary.

Sources and reading scope

Source links checked 5 October 2026. Research summaries use the accessible original abstract unless a full-text source is explicitly identified. Guidance documents and external supplier explanations are technical references, not NHD batch evidence or a claim of regulatory compliance. Any example introduced as hypothetical or teaching is a calculation, not a measured product result.

NHD catalogue materials are for qualified laboratory research, development and manufacturing enquiries. This article does not provide instructions for human or veterinary use.

Sources & editorial method

AI-assisted writing and source checks; conceptual illustrated cover.

2 linked records are listed in the references below. Read the editorial and AI-assistance policy.

How to interpret this article

Study results and labeled examples are separated. Original-source, arithmetic, readability and internal-link checks; no independent human peer review recorded.

Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.

Primary records and authoritative sources

  1. Thermo Fisher: Peptide Design guideChecked 2026-10-05; source scope is identified in the article.
  2. FDA: ICH Q2(R2), analytical procedure validationChecked 2026-10-05; source scope is identified in the article.
Research pathways

Continue with structured records

Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.

Editorial source check: Codex AI editorial · 2026-10-05